Literature DB >> 31944591

Distinguishing Specific CXCL12 Isoforms on Their Angiogenesis and Vascular Permeability Promoting Properties.

Chia-Wen Chang1, Alex J Seibel1, Alex Avendano2, Marcos G Cortes-Medina2, Jonathan W Song3,4.   

Abstract

Angiogenesis is associated with increased vessel sprouting and permeability. Important mediators of these angiogenic responses include local environment of signaling molecules and supporting extracellular matrix (ECM). However, dissecting the interplay of these instructive signals in vivo with multiple cells and extracellular molecules remains a central challenge. Here, microfluidic biomimicry is integrated with 3D ECM hydrogels that are well-characterized for molecular-binding and mechanical properties to reconstitute vessel-like analogues in vitro. This study focuses on three distinct isoforms of the pro-metastatic chemokine CXCL12. In collagen-only hydrogel, CXCL12-α is the most potent isoform in promoting sprouting and permeability, followed by CXCL12-β and CXCL12-γ. Strikingly, addition of hyaluronan (HA), a large and negatively charged glycosaminoglycan, with collagen matrices selectively increases vessel sprouting and permeability conferred by CXCL12-γ. This outcome is supported by the measured binding affinities to collagen/HA ECM, suggesting that negatively charged HA increases the binding of CXCL12-γ to augment its angiogenic potency. Moreover, it is shown that addition of HA to collagen matrices on its own decreases vessel sprouting and permeability, and these responses are nullified by blocking the HA receptor CD44. Collectively, these results demonstrate that differences in binding to extracellular HA help underlie CXCL12 isoform-specific responses toward directing angiogenesis.
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  chemokine; extracellular matrix; hyaluronic acid; matrix-bound ligands; microfluidics; microvessel analogues; vascular function

Mesh:

Substances:

Year:  2020        PMID: 31944591      PMCID: PMC7033017          DOI: 10.1002/adhm.201901399

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  52 in total

Review 1.  Hyaluronan: from extracellular glue to pericellular cue.

Authors:  Bryan P Toole
Journal:  Nat Rev Cancer       Date:  2004-07       Impact factor: 60.716

Review 2.  Angiogenesis in life, disease and medicine.

Authors:  Peter Carmeliet
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

Review 3.  Functions of CXCL12 and CXCR4 in breast cancer.

Authors:  Kathryn E Luker; Gary D Luker
Journal:  Cancer Lett       Date:  2005-07-25       Impact factor: 8.679

Review 4.  CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

Authors:  Dan G Duda; Sergey V Kozin; Nathaniel D Kirkpatrick; Lei Xu; Dai Fukumura; Rakesh K Jain
Journal:  Clin Cancer Res       Date:  2011-02-24       Impact factor: 12.531

Review 5.  Balancing forces: architectural control of mechanotransduction.

Authors:  Christopher C DuFort; Matthew J Paszek; Valerie M Weaver
Journal:  Nat Rev Mol Cell Biol       Date:  2011-05       Impact factor: 94.444

Review 6.  Molecular mechanisms and clinical applications of angiogenesis.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

7.  Surface-templated hydrogel patterns prompt matrix-dependent migration of breast cancer cells towards chemokine-secreting cells.

Authors:  Taisuke Kojima; Christopher Moraes; Stephen P Cavnar; Gary D Luker; Shuichi Takayama
Journal:  Acta Biomater       Date:  2014-11-24       Impact factor: 8.947

Review 8.  The role of adherens junctions and VE-cadherin in the control of vascular permeability.

Authors:  Elisabetta Dejana; Fabrizio Orsenigo; Maria Grazia Lampugnani
Journal:  J Cell Sci       Date:  2008-07-01       Impact factor: 5.285

9.  Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.

Authors:  Thomas R Cox; Janine T Erler
Journal:  Dis Model Mech       Date:  2011-02-14       Impact factor: 5.758

10.  Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels.

Authors:  Vikash P Chauhan; John D Martin; Hao Liu; Delphine A Lacorre; Saloni R Jain; Sergey V Kozin; Triantafyllos Stylianopoulos; Ahmed S Mousa; Xiaoxing Han; Pichet Adstamongkonkul; Zoran Popović; Peigen Huang; Moungi G Bawendi; Yves Boucher; Rakesh K Jain
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  5 in total

1.  The biophysics of cancer: emerging insights from micro- and nanoscale tools.

Authors:  Peter E Beshay; Marcos G Cortes-Medina; Miles M Menyhert; Jonathan W Song
Journal:  Adv Nanobiomed Res       Date:  2021-11-23

Review 2.  Endothelial glycocalyx as an important factor in composition of blood-brain barrier.

Authors:  Fangfang Zhao; Liyuan Zhong; Yumin Luo
Journal:  CNS Neurosci Ther       Date:  2020-12-30       Impact factor: 7.035

Review 3.  Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues.

Authors:  Lin-Cui Da; Yan Sun; Yun-Hong Lin; Su-Zhu Chen; Gang-Xin Chen; Bei-Hong Zheng; Sheng-Rong Du
Journal:  Pharmaceutics       Date:  2022-08-17       Impact factor: 6.525

4.  Fibroblast-derived CXCL12 increases vascular permeability in a 3-D microfluidic model independent of extracellular matrix contractility.

Authors:  Jacob C Holter; Chia-Wen Chang; Alex Avendano; Ayush A Garg; Ajeet K Verma; Manish Charan; Dinesh K Ahirwar; Ramesh K Ganju; Jonathan W Song
Journal:  Front Bioeng Biotechnol       Date:  2022-09-02

Review 5.  Vessel-on-a-chip models for studying microvascular physiology, transport, and function in vitro.

Authors:  Savannah R Moses; Jonathan J Adorno; Andre F Palmer; Jonathan W Song
Journal:  Am J Physiol Cell Physiol       Date:  2020-11-11       Impact factor: 4.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.